Mirum Pharmaceuticals (MIRM) Q3 2023 Earnings

2NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-1.94
-1.48
-1.03
-0.57

Details

Expected EPS
-0.65
Actual EPS
-0.57
Surprise EPS
0.08
Surprise Percent
+12.31%

Description

Mirum Pharmaceuticals (MIRM) has reported earnings of -0.57 per share for Q3 2023.

0 Comments

Share your thoughts